Chasing Regeneron, AZ starts trials of its COVID-19 antibody cocktail
pharmaphorum
AUGUST 25, 2020
The first patients have been dosed in a trial of two AstraZeneca antibodies, collectively known as AZD7442, that are being developed to both treat and prevent coronavirus infections. The phase 1 trial – funded by the US government – will take place in the UK and will test the safety of AZD7442 and its pharmacokinetic profile.
84 
Let's personalize your content